Page 11 of 12

MI3.10-13 | Blood & Tissue Parasites and HIV/AIDS — Case Study

CLINICAL SCENARIO

A 27-year-old patient presenting to a rural health centre in Rajasthan is referred to a tertiary hospital with a 5-day history of high-grade fever (temperature 40.2°C), headache, vomiting, and altered consciousness. She is a migrant worker who recently returned from a construction site in Assam. On examination: pallor, icterus, splenomegaly, and GCS score of 9/15. Vital signs: BP 90/60 mmHg, HR 118/min, RR 24/min. Blood glucose: 42 mg/dL (hypoglycaemia). Peripheral blood smear shows ring forms in nearly 12% of RBCs, multiple rings per cell, and occasional crescentic gametocytes in normal-sized RBCs. Thick film confirms heavy parasitaemia. Rapid Diagnostic Test (HRP-2-based) is strongly positive. Serum LDH and bilirubin are markedly elevated. Urine is dark brown ('Coca-Cola' coloured).

Instructions

You are a Year-2 MBBS student on your Microbiology clinical posting. Based on the clinical scenario above, write a structured case analysis addressing the sections below.

Word guidance: 600–800 words total.

Use appropriate medical terminology. Your analysis should demonstrate understanding of malaria pathogenesis, peripheral smear interpretation, and the clinical significance of complications.

Section 1: Peripheral Smear Interpretation & Species Identification (15 points)

Analyse the peripheral smear findings described. Identify the Plasmodium species with justification. List at least 4 specific morphological features that confirm your diagnosis. Explain why only ring forms and gametocytes are visible on the smear.

Section 2: Pathogenesis of Complications (15 points)

This patient has cerebral malaria, severe anaemia, blackwater fever, and hypoglycaemia. For EACH complication, briefly explain the underlying pathogenic mechanism at the cellular/molecular level (2–3 sentences per complication).

Section 3: Laboratory Diagnosis — Choosing the Right Test (10 points)

The RDT is positive. The treating physician wants to confirm species and quantify parasitaemia. State which laboratory tests you would recommend (with brief rationale for each). Explain the advantage of HRP-2-based RDT over pLDH-based tests for this specific case.

Section 4: Management Priorities and Anti-malarial Rationale (10 points)

List the immediate management priorities in order. Identify the recommended first-line anti-malarial for severe falciparum malaria (per WHO/NVBDCP guidelines) and explain why it is preferred over quinine. Discuss one important drug safety consideration in this patient.

Length: 600-800 words

What to Submit

Section 1: Peripheral Smear Interpretation & Species Identification

Based on the described smear findings — 12% parasitaemia, multiple rings per RBC, crescentic gametocytes, normal RBC size — identify the species and justify with morphological criteria. Why are only rings and gametocytes visible (not mature trophozoites or schizonts)?

Guidance: Focus on: (1) RBC size, (2) multiple rings per cell, (3) appliqué/accolé forms, (4) gametocyte shape, (5) sequestration phenomenon (PfEMP-1 and cytoadherence) explaining absence of mature stages on peripheral smear.

Section 2: Pathogenesis of Complications

For each complication — cerebral malaria, severe haemolytic anaemia, blackwater fever, hypoglycaemia — explain the molecular or cellular mechanism in 2–3 sentences.

Guidance: Cerebral malaria: PfEMP-1 → cytoadherence to ICAM-1/CD36 → microvascular obstruction + TNF-α release. Blackwater fever: massive intravascular haemolysis → haemoglobinuria. Hypoglycaemia: parasite consumes glucose + quinine stimulates insulin. Anaemia: RBC destruction + dyserythropoiesis.

Section 3: Laboratory Diagnosis

List the laboratory investigations needed: thick and thin film, RDT, and any additional tests. Compare HRP-2-based vs pLDH-based RDTs for this scenario.

Guidance: Thick film: species ID + parasitaemia quantification (gold standard). RDT (HRP-2): rapid, falciparum-specific. HRP-2 advantage over pLDH: detects at lower parasitaemia and remains positive longer (useful when parasitaemia is dropping). Optional: PCR for species confirmation.

Section 4: Management Priorities and Anti-malarial Rationale

List the immediate priorities (airway, blood glucose, anti-malarials, ICU). Name the first-line anti-malarial for severe falciparum malaria per WHO/NVBDCP, compare to quinine, and note one drug safety concern in this patient.

Guidance: IV artesunate is first-line for severe falciparum malaria (WHO/NVBDCP) over quinine: faster parasite clearance, fewer adverse effects (quinine → hypoglycaemia, cardiac arrhythmia). Safety concern: monitor blood glucose (quinine stimulates insulin release; artesunate is safer but glucose monitoring still essential). Also: avoid primaquine (dark urine suggests G6PD risk).

Grading Rubric — Blood & Tissue Parasites and HIV/AIDS — Case Study Rubric (50 points)

Criterion	Points	Full-marks descriptor
Peripheral Smear Interpretation — Species Identification with Morphological Justification	15 pts	Correctly identifies P. falciparum. Lists ≥4 specific morphological features (multiple rings/RBC, normal RBC size, appliqué/accolé forms, crescentic gametocytes, >2% parasitaemia). Accurately explains cytoadherence/sequestration as the reason only rings and gametocytes circulate.
Pathogenesis of Complications — Cerebral Malaria, Anaemia, Blackwater Fever, Hypoglycaemia	15 pts	All 4 complications addressed accurately with mechanistic explanation: cerebral = PfEMP-1 cytoadherence; blackwater fever = massive intravascular haemolysis → haemoglobinuria; anaemia = RBC destruction + dyserythropoiesis; hypoglycaemia = glucose consumption by parasites + drug (quinine) effect. Each explained in 2–3 clear sentences.
Laboratory Diagnosis — Selection and Rationale, HRP-2 vs pLDH Comparison	10 pts	Thick + thin film recommended with clear rationale (gold standard, quantify parasitaemia). HRP-2 vs pLDH comparison: HRP-2 = falciparum-specific, high sensitivity, persists after parasite clearance; pLDH = pan-malarial, better for monitoring treatment response (becomes negative when parasites clear). Rationale for additional tests (PCR) if mentioned is appropriate.
Management Priorities and Anti-malarial Drug Rationale	10 pts	Correct priority order (airway/circulation, correct hypoglycaemia with IV dextrose, IV artesunate for severe falciparum). Artesunate preferred over quinine: faster parasite clearance, fewer serious adverse effects (cardiac arrhythmia, hypoglycaemia from quinine). Safety concern appropriately identified (e.g., glucose monitoring, avoid primaquine in possible G6PD deficiency, renal monitoring).

PEER REVIEW

Review your peer's case analysis using the following criteria:

Species identification accuracy: Did they correctly identify P. falciparum and justify with specific morphological criteria from the smear description?

Pathogenic mechanisms: For each complication (cerebral malaria, anaemia, blackwater fever, hypoglycaemia), did they explain the mechanism at a cellular/molecular level — not just describe the symptom?

Laboratory reasoning: Did they recommend appropriate tests with clear justification? Was the HRP-2 vs pLDH comparison accurate and clinically meaningful?

Management priorities: Are the immediate management steps listed in a logical order of clinical urgency? Is IV artesunate identified as first-line with a valid reason for preference over quinine?

Overall clarity: Is the response well-structured, using appropriate medical terminology? Does it stay within the 600–800 word guidance?

Provide constructive, specific feedback. Point out any factual inaccuracies (e.g., incorrect drug name, wrong mechanism). Rate the response on a scale of 1–5 overall.